BAP1 and nonpapillary renal cell carcinoma: Such alterations may include BAP1 loss (15% of all ccRCC tumors) that is associated with an aggressive ccRCC phenotype and promotes ferroptosis escape by increasing SLC7a11-mediated cysteine uptake for antioxidant production (101, 102).